Filtered By:
Source: Medscape Psychiatry Headlines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 90 results found since Jan 2013.
FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage
In a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.Medscape Medical News
Source: Medscape Psychiatry Headlines - August 2, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news
Reassuring Data on Stimulants for ADHD and Substance Abuse Reassuring Data on Stimulants for ADHD and Substance Abuse
There is no increased risk of substance abuse later in life among children treated with stimulants for ADHD, results of a large longitudinal study show.Medscape Medical News
Source: Medscape Psychiatry Headlines - July 26, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news
Olympic Medalist Molly Seidel Makes Strides With Her ADHD Olympic Medalist Molly Seidel Makes Strides With Her ADHD
In part 3 of this video series, marathon runner Molly Seidel teaches others about the importance of working on her mental health daily.WebMD
Source: Medscape Psychiatry Headlines - May 3, 2023 Category: Psychiatry Tags: Psychiatry Expert Interview Source Type: news
Runner Molly Seidel Takes Control of her ADHD Diagnosis Runner Molly Seidel Takes Control of her ADHD Diagnosis
Part 2: After years of playing “whack-a-mole” to find an ADHD diagnosis, Olympic bronze medalist Molly Seidel stresses the importance of an open dialog between patients and healthcare professionals.WebMD
Source: Medscape Psychiatry Headlines - April 26, 2023 Category: Psychiatry Tags: Psychiatry Commentary Source Type: news
Olympic Medalist and ADHD Patient Molly Seidel on Her Journey Olympic Medalist and ADHD Patient Molly Seidel on Her Journey
The marathon runner and Olympic bronze medalist has a lot to teach clinicians and patients about how to successfully conquer the triple threat of ADHD, OCD, and an eating disorder.WebMD
Source: Medscape Psychiatry Headlines - April 14, 2023 Category: Psychiatry Tags: Psychiatry Commentary Source Type: news
Once-Daily Stimulant for ADHD Safe, Effective at 1 Year Once-Daily Stimulant for ADHD Safe, Effective at 1 Year
A once-daily oral stimulant medication for treatment of ADHD in individuals aged 6 years or older is safe and effective after 1 year of treatment, new research shows.Medscape Medical News
Source: Medscape Psychiatry Headlines - March 9, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news
Struggling to Focus? Try Video Games Struggling to Focus? Try Video Games
You may know that video games can help kids with ADHD, but growing research suggests they could aid attention and working memory for just about everyone.WebMD Health News
Source: Medscape Psychiatry Headlines - November 28, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
FDA Confirms Nationwide Adderall Shortage FDA Confirms Nationwide Adderall Shortage
The US Food and Drug Administration says it is in frequent contact with all manufacturers to monitor the supply of Adderall, which is approved for treating ADHD, and to help resolve this shortage.Medscape Medical News
Source: Medscape Psychiatry Headlines - October 13, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
Repurposed ADHD Meds Effective for Alzheimer ' s Disease? Repurposed ADHD Meds Effective for Alzheimer ' s Disease?
Pooled data provide"good evidence" that noradrenergic drugs may help ease cognitive symptoms and apathy in patients with Alzheimer ' s disease.Medscape Medical News
Source: Medscape Psychiatry Headlines - July 11, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
Triptans in Pregnancy and ADHD in Kids: New Reassuring Data Triptans in Pregnancy and ADHD in Kids: New Reassuring Data
Study results now extend evidence on the safety of of triptans for migraine in pregnancy and should reassure women who need to take this class of drugs while expecting.Medscape Medical News
Source: Medscape Psychiatry Headlines - June 14, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
ADHD Genetic Risk Probed as Biomarker for Alzheimer ADHD Genetic Risk Probed as Biomarker for Alzheimer
People with a genetic predisposition to attention deficit hyperactivity disorder (ADHD) might also be more susceptible to tau pathology and cognitive decline, according to a new preliminary study.First Look
Source: Medscape Psychiatry Headlines - April 22, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
Autism, ADHD Linked to Increased Mortality Risk Autism, ADHD Linked to Increased Mortality Risk
All-cause mortality is significantly higher for individuals with autism spectrum disorder or attention-deficit/hyperactivity disorder than for the general population, a study shows.Medscape Medical News
Source: Medscape Psychiatry Headlines - February 17, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news
Novel Drug May Lower Agitation in Multiple Psychiatric Disorders Novel Drug May Lower Agitation in Multiple Psychiatric Disorders
Vafidemstat may reduce agitation and aggression in autism, ADHD, and borderline personality disorder. It ' s also the first psychiatric drug with an epigenetic mode of action, investigators say.Medscape Medical News
Source: Medscape Psychiatry Headlines - July 24, 2020 Category: Psychiatry Tags: Psychiatry News Source Type: news
FDA Approves Video Game-Based Therapy for Kids With ADHD FDA Approves Video Game-Based Therapy for Kids With ADHD
The FDA granted marketing authorization for a digital game-based therapy that improves attention function in children with attention-deficit/hyperactivity disorder (ADHD).FDA Approvals
Source: Medscape Psychiatry Headlines - June 16, 2020 Category: Psychiatry Tags: Pediatrics News Alert Source Type: news
No Increased CVD Event Risk With ADHD Meds in Kids With Autism No Increased CVD Event Risk With ADHD Meds in Kids With Autism
A database analysis of more than 300,000 individuals concludes there is no increased risk for adverse cardiovascular events associated with the use of stimulant medications by children and youth with autism.Medscape Medical News
Source: Medscape Psychiatry Headlines - November 8, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news
